Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI
NCT03911895 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2019-04-11
Summary
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
Conditions
- Stable Chronic Angina
Interventions
- DEVICE
-
Stent more than 26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
- DEVICE
-
Stent equal to or less than26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 25 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2020-06-30
- Completion
- 2020-09-30
- FDA Device
- Yes
Countries
- Egypt
Study Locations
More Related Trials
-
Serial OCT Evaluation of Tissue Coverage in Patients Submitted to Inspiron Drug Eluting Stent Implantation
NCT03269461 ·Status: COMPLETED ·Phase: NA
-
the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction
NCT03199014 ·Status: UNKNOWN ·Phase: NA
-
StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation
NCT03401216 ·Status: UNKNOWN ·Phase: NA
-
The First Jordanian PCI Registry: Events at 1 Year
NCT01841346 ·Status: COMPLETED
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting
NCT01534221 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent
NCT01308229 ·Status: COMPLETED ·Phase: NA
-
Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent
NCT01012583 ·Status: UNKNOWN
-
Antiplatelet Therapy Following Stent Implantation
NCT02051361 ·Status: COMPLETED
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
The 3D Stent Study
NCT06898021 ·Status: RECRUITING
-
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038 ·Status: COMPLETED
-
Very Long Versus Overlapping Stents in Long Coronary Lesions
NCT04738344 ·Status: WITHDRAWN ·Phase: NA
-
INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique
NCT03780192 ·Status: UNKNOWN
-
Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies
NCT00396929 ·Status: UNKNOWN ·Phase: PHASE3
-
Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI
NCT02979236 ·Status: UNKNOWN
-
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
NCT01835301 ·Status: UNKNOWN
-
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
NCT00811772 ·Status: COMPLETED ·Phase: NA
-
Optical Coherence Tomography in Long Lesions
NCT01133925 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up
NCT02384837 ·Status: COMPLETED
-
Xience Versus Synergy in Left Main PCI
NCT02303717 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
NCT04135989 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation
NCT02504307 ·Status: COMPLETED ·Phase: PHASE4